Bush's Drug-Patent Move Makes Generics Hot Topic


The inability of President Bush and Congress to come to terms on such hot-button health care issues as HMO liability and Medicare drug coverage has helped to push another topic to the fore: the availability of generic drugs.

Bush on Oct. 21 proposed a regulation that reduces the amount of time that patents can protect name-brand medications from competition. Suddenly, the issue promises to be the focus of intense debate for the next two months.

It didn't take long for opposing sides to line up, either. At press time, lawyers for major drug companies were predicting that the industry will file a lawsuit against the regulation, while health insurance administrators, the AARP, and the generic drug industry came out foursquare in favor of Bush's change. Meanwhile, some have argued that the move is simply political posturing in an election season.

The proposal, published in the Oct. 24 Federal Register, will undergo 60 days of public comment before a final version is issued.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.